In this exclusive video interview, Manufacturing Chemist talks to the VP of Portfolio and Sourcing from the CDMO Curia about getting a drug from discovery to commercial scale manufacturing as quickly and efficiently as possible
This article is sponsored by Curia
Curia is an end-to-end CDMO, which aims to help pharmaceutical and biotech companies overcome hurdles to improve patients’ lives.
In this interview, the company's VP of Portfolio and Sourcing, James Grabowski, discusses some of his highlights and milestones at the company, and delves into some of the commercial launches he is proud to look back on.
Grabowski also talks about Curia's "from curiosity to care" movement and the ways in which it helps customers overcome challenges from discovery to commercial scale manufacturing. He explains that drug manufacturers can get caught up in the day-to-day, and fail to see the bigger picture issues that can lead to problems down the road.
'Manufacturing Chemist in conversation with' is a series of exclusive video interviews with leading companies in the cleanroom industry, conducted by our team of B2B journalists.
For more information on how you can be part of 'Manufacturing Chemist in conversation with' contact Don Phares via firstname.lastname@example.org or +44 (0) 207 193 3219.
This interview was led by Sophie Bullimore from Manufacturing Chemist.